The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Lentiviral vectors: basic to translational
Abstract
More than two decades have passed since genetically modified HIV was used for gene delivery. Through continuous improvements these early marker gene-carrying HIVs have evolved into safer and more effective lentiviral vectors. Lentiviral vectors offer several attractive properties as gene-delivery vehicles, including: (i) sustained gene delivery through stable vector integration into host genome; (ii) the capability of infecting both dividing and non-dividing cells; (iii) broad tissue tropisms, including important gene- and cell-therapy-target cell types; (iv) no expression of viral proteins after vector transduction; (v) the ability to deliver complex genetic elements, such as polycistronic or intron-containing sequences; (vi) potentially safer integration site profile; and (vii) a relatively easy system for vector manipulation and production. Accordingly, lentivector technologies now have widespread use in basic biology and translational studies for stable transgene overexpression, persistent gene silencing, immunization, in vivo imaging, generating transgenic animals, induction of pluripotent cells, stem cell modification and lineage tracking, or site-directed gene editing. Moreover, in the present high-throughput ‘-omics’ era, the commercial availability of premade lentiviral vectors, which are engineered to express or silence genome-wide genes, accelerates the rapid expansion of this vector technology. In the present review, we assess the advances in lentiviral vector technology, including basic lentivirology, vector designs for improved efficiency and biosafety, protocols for vector production and infection, targeted gene delivery, advanced lentiviral applications and issues associated with the vector system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells
Hammond, S. M., Bernstein, E., Beach, D., & Hannon, G. J. (2000) · Nature · doi:10.1038/35005107 · Cited by 3,003
Transcriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors
Ieda, M., Fu, J.-D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G., & Srivastava, D. (2010) · Cell · doi:10.1016/j.cell.2010.07.002 · Cited by 2,454
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
Cavazzana-Calvo, M., Hacein-Bey, S., Basile, G. D. S., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.-L., et al. (2000) · Science · doi:10.1126/science.288.5466.669 · Cited by 2,167
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,999
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery
Zufferey, R., Dull, T., Mandel, R. J., Bukovsky, A., Quiroz, D., Naldini, L., & Trono, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9873-9880.1998 · Cited by 1,815
Lentivirus-delivered stable gene silencing by RNAi in primary cells
STEWART, S. A., DYKXHOORN, D. M., PALLISER, D., MIZUNO, H., YU, E. Y., AN, D. S., SABATINI, D. M., CHEN, I. S. Y., HAHN, W. C., SHARP, P. A., et al. (2003) · RNA · doi:10.1261/rna.2192803 · Cited by 1,582
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., & Conklin, D. S. (2002) · Genes & Development · doi:10.1101/gad.981002 · Cited by 1,552
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508
Naldini, L., Blömer, U., Gage, F. H., Trono, D., & Verma, I. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11382 · Cited by 1,499
Lai, E. C. (2002) · Nature Genetics · doi:10.1038/ng865 · Cited by 1,473
Burns, J. C., Friedmann, T., Driever, W., Burrascano, M., & Yee, J. K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8033 · Cited by 1,399
Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305
Malim, M. H., Hauber, J., Le, S.-Y., Maizel, J. V., & Cullen, B. R. (1989) · Nature · doi:10.1038/338254a0 · Cited by 1,280
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Cavazzana-Calvo, M., Payen, E., Negre, O., Wang, G., Hehir, K., Fusil, F., Down, J., Denaro, M., Brady, T., Westerman, K., et al. (2010) · Nature · doi:10.1038/nature09328 · Cited by 1,276
DNA Deamination Mediates Innate Immunity to Retroviral Infection
Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., & Malim, M. H. (2003) · Cell · doi:10.1016/s0092-8674(03)00423-9 · Cited by 1,266
Wei, P., Garber, M. E., Fang, S.-M., Fischer, W. H., & Jones, K. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80939-3 · Cited by 1,249
Development of a self-inactivating lentivirus vector
Miyoshi, H., Blömer, U., Takahashi, M., Gage, F. H., & Verma, I. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8150-8157.1998 · Cited by 1,196
Szymczak, A. L., Workman, C. J., Wang, Y., Vignali, K. M., Dilioglou, S., Vanin, E. F., & Vignali, D. A. A. (2004) · Nature Biotechnology · doi:10.1038/nbt957 · Cited by 1,059
An improved zinc-finger nuclease architecture for highly specific genome editing
Miller, J. C., Holmes, M. C., Wang, J., Guschin, D. Y., Lee, Y.-L., Rupniewski, I., Beausejour, C. M., Waite, A. J., Wang, N. S., Kim, K. A., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1319 · Cited by 1,051
HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D., & Baltimore, D. (1998) · Nature · doi:10.1038/34929 · Cited by 1,021
Zufferey, R., Donello, J. E., Trono, D., & Hope, T. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2886-2892.1999 · Cited by 1,014
Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences
Mitchell, R. S., Beitzel, B. F., Schroder, A. R. W., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020234 · Cited by 976
Induction of an interferon response by RNAi vectors in mammalian cells
Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A.-L., & Iggo, R. (2003) · Nature Genetics · doi:10.1038/ng1173 · Cited by 961
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors
Huang, P., He, Z., Ji, S., Sun, H., Xiang, D., Liu, C., Hu, Y., Wang, X., & Hui, L. (2011) · Nature · doi:10.1038/nature10116 · Cited by 864
Lombardo, A., Genovese, P., Beausejour, C. M., Colleoni, S., Lee, Y.-L., Kim, K. A., Ando, D., Urnov, F. D., Galli, C., Gregory, P. D., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1353 · Cited by 845
HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap
Zennou, V., Petit, C., Guetard, D., Nerhbass, U., Montagnier, L., & Charneau, P. (2000) · Cell · doi:10.1016/s0092-8674(00)80828-4 · Cited by 833
Bukrinsky, M. I., Haggerty, S., Dempsey, M. P., Sharova, N., Adzhubei, A., Spitz, L., Lewis, P., Goldfarb, D., Emerman, M., & Stevenson, M. (1993) · Nature · doi:10.1038/365666a0 · Cited by 802
Wiznerowicz, M., & Trono, D. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8957-8951.2003 · Cited by 701
Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Ponzoni, M., Bartholomae, C., Sergi, L. S., Benedicenti, F., Ambrosi, A., Di Serio, C., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1216 · Cited by 701
Gaspar, H. B., Parsley, K. L., Howe, S., King, D., Gilmour, K. C., Sinclair, J., Brouns, G., Schmidt, M., Von Kalle, C., Barington, T., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17590-9 · Cited by 689
A role for LEDGF/p75 in targeting HIV DNA integration
Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R., & Bushman, F. (2005) · Nature Medicine · doi:10.1038/nm1329 · Cited by 658
Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency
Hacein-Bey-Abina, S., Hauer, J., Lim, A., Picard, C., Wang, G. P., Berry, C. C., Martinache, C., Rieux-Laucat, F., Latour, S., Belohradsky, B. H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000164 · Cited by 639
Cre-lox-regulated conditional RNA interference from transgenes
Ventura, A., Meissner, A., Dillon, C. P., McManus, M., Sharp, P. A., Van Parijs, L., Jaenisch, R., & Jacks, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403954101 · Cited by 625
Subramanyam, D., Lamouille, S., Judson, R. L., Liu, J. Y., Bucay, N., Derynck, R., & Blelloch, R. (2011) · Nature Biotechnology · doi:10.1038/nbt.1862 · Cited by 598
Correction of sickle cell disease in transgenic mouse models by gene therapy
Pawliuk, R., Westerman, K. A., Fabry, M. E., Payen, E., Tighe, R., Bouhassira, E. E., Acharya, S. A., Ellis, J., London, I. M., Eaves, C. J., et al. (2001) · Science · doi:10.1126/science.1065806 · Cited by 579
Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Bartholomae, C. C., Ranzani, M., Benedicenti, F., Sergi, L. S., Ambrosi, A., Ponzoni, M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37630 · Cited by 571
HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation
Laspia, M. F., Rice, A. P., & Mathews, M. B. (1989) · Cell · doi:10.1016/0092-8674(89)90290-0 · Cited by 571
May, C., Rivella, S., Callegari, J., Heller, G., Gaensler, K. M. L., Luzzatto, L., & Sadelain, M. (2000) · Nature · doi:10.1038/35017565 · Cited by 567
Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus
SONIGO, P., ALIZON, M., STASKUS, K., KLATZMANN, D., COLE, S., DANOS, O., RETZEL, E., TIOLLAIS, P., HAASE, A., & WAINHOBSON, S. (1985) · Cell · doi:10.1016/s0092-8674(85)80132-x · Cited by 565
De Palma, M., Venneri, M. A., Roca, C., & Naldini, L. (2003) · Nature Medicine · doi:10.1038/nm871 · Cited by 549
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.
Yu, S. F., von Rüden, T., Kantoff, P. W., Garber, C., Seiberg, M., Rüther, U., Anderson, W. F., Wagner, E. F., & Gilboa, E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3194 · Cited by 541
Tiscornia, G., Singer, O., Ikawa, M., & Verma, I. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437912100 · Cited by 540
An essential role for LEDGF/p75 in HIV integration
Llano, M., Saenz, D. T., Meehan, A., Wongthida, P., Peretz, M., Walker, W. H., Teo, W., & Poeschla, E. M. (2006) · Science · doi:10.1126/science.1132319 · Cited by 537
Pfeifer, A., Ikawa, M., Dayn, Y., & Verma, I. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251682798 · Cited by 522
Reprogramming of murine and human somatic cells using a single polycistronic vector
Carey, B. W., Markoulaki, S., Hanna, J., Saha, K., Gao, Q., Mitalipova, M., & Jaenisch, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811426106 · Cited by 503
Gene transfer in humans using a conditionally replicating lentiviral vector
Levine, B. L., Humeau, L. M., Boyer, J., MacGregor, R.-R., Rebello, T., Lu, X., Binder, G. K., Slepushkin, V., Lemiale, F., Mascola, J. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608138103 · Cited by 501
Demaison, C., Parsley, K., Brouns, G., Scherr, M., Battmer, K., Kinnon, C., Grez, M., & Thrasher, A. J. (2002) · Human Gene Therapy · doi:10.1089/10430340252898984 · Cited by 486
Raoul, C., Abbas-Terki, T., Bensadoun, J.-C., Guillot, S., Haase, G., Szulc, J., Henderson, C. E., & Aebischer, P. (2005) · Nature Medicine · doi:10.1038/nm1207 · Cited by 464
Effective gene therapy with nonintegrating lentiviral vectors
Yáñez-Muñoz, R. J., Balaggan, K. S., MacNeil, A., Howe, S. J., Schmidt, M., Smith, A. J., Buch, P., MacLaren, R. E., Anderson, P. N., Barker, S. E., et al. (2006) · Nature Medicine · doi:10.1038/nm1365 · Cited by 460
Poeschla, E. M., Wong-Staal, F., & Looney, D. J. (1998) · Nature Medicine · doi:10.1038/nm0398-354 · Cited by 416
Modlich, U., Navarro, S., Zychlinski, D., Maetzig, T., Knoess, S., Brugman, M. H., Schambach, A., Charrier, S., Galy, A., Thrasher, A. J., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.179 · Cited by 387
Efficient production of germline transgenic chickens using lentiviral vectors
McGrew, M. J., Sherman, A., Ellard, F. M., Lillico, S. G., Gilhooley, H. J., Kingsman, A. J., Mitrophanous, K. A., & Sang, H. (2004) · EMBO reports · doi:10.1038/sj.embor.7400171 · Cited by 379
Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element
Donello, J. E., Loeb, J. E., & Hope, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5085-5092.1998 · Cited by 350
Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity
Page, K. A., Landau, N. R., & Littman, D. R. (1990) · Journal of Virology · doi:10.1128/jvi.64.11.5270-5276.1990 · Cited by 348
Proteolytic refolding of the HIV‐1 capsid protein amino‐terminus facilitates viral core assembly
von Schwedler, U. K., Stemmler, T. L., Klishko, V. Y., Li, S., Albertine, K. H., Davis, D. R., & Sundquist, W. I. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1555 · Cited by 337
Imaging tri-fusion multimodality reporter gene expression in living subjects
Ray, P., De, A., Min, J.-J., Tsien, R. Y., & Gambhir, S. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1816 · Cited by 329
Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters
Amendola, M., Venneri, M. A., Biffi, A., Vigna, E., & Naldini, L. (2005) · Nature Biotechnology · doi:10.1038/nbt1049 · Cited by 324
Lo Bianco, C., Schneider, B. L., Bauer, M., Sajadi, A., Brice, A., Iwatsubo, T., & Aebischer, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405313101 · Cited by 322
Akkina, R. K., Walton, R. M., Chen, M. L., Li, Q. X., Planelles, V, & Chen, I. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2581-2585.1996 · Cited by 321
Charneau, P., Alizon, M., & Clavel, F. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.2814-2820.1992 · Cited by 312
Mervis, R. J., Ahmad, N., Lillehoj, E. P., Raum, M. G., Salazar, F. H., Chan, H. W., & Venkatesan, S. (1988) · Journal of Virology · doi:10.1128/jvi.62.11.3993-4002.1988 · Cited by 310
Mochizuki, H., Schwartz, J. P., Tanaka, K., Brady, R. O., & Reiser, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8873-8883.1998 · Cited by 308
Sandrin, V., Boson, B., Salmon, P., Gay, W., Nègre, D., Le Grand, R., Trono, D., & Cosset, F.-L. (2002) · Blood · doi:10.1182/blood-2001-11-0042 · Cited by 305
Stable knockdown of microRNA in vivo by lentiviral vectors
Gentner, B., Schira, G., Giustacchini, A., Amendola, M., Brown, B. D., Ponzoni, M., & Naldini, L. (2009) · Nature Methods · doi:10.1038/nmeth.1277 · Cited by 304
Therapeutic gene causing lymphoma
Woods, N.-B., Bottero, V., Schmidt, M., von Kalle, C., & Verma, I. M. (2006) · Nature · doi:10.1038/4401123a · Cited by 288
Henderson, L. E., Bowers, M. A., Sowder, R. C., Serabyn, S. A., Johnson, D. G., Bess, J. W., Arthur, L. O., Bryant, D. K., & Fenselau, C. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.1856-1865.1992 · Cited by 283
Efficient transgenesis in farm animals by lentiviral vectors
Hofmann, A., Kessler, B., Ewerling, S., Weppert, M., Vogg, B., Ludwig, H., Stojkovic, M., Boelhauve, M., Brem, G., Wolf, E., et al. (2003) · EMBO reports · doi:10.1038/sj.embor.7400007 · Cited by 280
Stable gene transfer to the nervous system using a non-primate lentiviral vector
Mitrophanous, K. A., Yoon, S., Rohll, J. B., Patil, D., Wilkes, F. J., Kim, V. N., Kingsman, S. M., Kingsman, A. J., & Mazarakis, N. D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301023 · Cited by 278
Landau, N. R., Page, K. A., & Littman, D. R. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.162-169.1991 · Cited by 271
Minimal Requirement for a Lentivirus Vector Based on Human Immunodeficiency Virus Type 1
Kim, V. N., Mitrophanous, K., Kingsman, S. M., & Kingsman, A. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.811-816.1998 · Cited by 269
Schwartz, S., Felber, B. K., & Pavlakis, G. N. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.150-159.1992 · Cited by 266
Helseth, E., Kowalski, M., Gabuzda, D., Olshevsky, U., Haseltine, W., & Sodroski, J. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2416-2420.1990 · Cited by 260
A Packaging Cell Line for Lentivirus Vectors
Kafri, T., van Praag, H., Ouyang, L., Gage, F. H., & Verma, I. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.576-584.1999 · Cited by 256
A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice
Brown, B. D., Cantore, A., Annoni, A., Sergi, L. S., Lombardo, A., Della Valle, P., D'Angelo, A., & Naldini, L. (2007) · Blood · doi:10.1182/blood-2007-03-078493 · Cited by 252
Philippe, S., Sarkis, C., Barkats, M., Mammeri, H., Ladroue, C., Petit, C., Mallet, J., & Serguera, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606197103 · Cited by 249
Lentiviral Vectors: Regulated Gene Expression
Kafri, T., van Praag, H., Gage, F. H., & Verma, I. M. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0083 · Cited by 246
Themis, M., Waddington, S. N., Schmidt, M., von Kalle, C., Wang, Y., Al-Allaf, F., Gregory, L. G., Nivsarkar, M., Themis, M., Holder, M. V., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.07.358 · Cited by 243
Li, M.-J., Kim, J., Li, S., Zaia, J., Yee, J.-K., Anderson, J., Akkina, R., & Rossi, J. J. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.07.524 · Cited by 241
VandenDriessche, T., Thorrez, L., Naldini, L., Follenzi, A., Moons, L., Berneman, Z., Collen, D., & Chuah, M. K. L. (2002) · Blood · doi:10.1182/blood.v100.3.813 · Cited by 236
Leavitt, A. D., Robles, G., Alesandro, N., & Varmus, H. E. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.721-728.1996 · Cited by 232
Kotsopoulou, E., Kim, V. N., Kingsman, A. J., Kingsman, S. M., & Mitrophanous, K. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4839-4852.2000 · Cited by 229
Pfeifer, A., Brandon, E. P., Kootstra, N., Gage, F. H., & Verma, I. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201415498 · Cited by 224
Olmsted, R. A., Hirsch, V. M., Purcell, R. H., & Johnson, P. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.8088 · Cited by 220
Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection
Morizono, K., Xie, Y., Ringpis, G.-E., Johnson, M., Nassanian, H., Lee, B., Wu, L., & Chen, I. S. Y. (2005) · Nature Medicine · doi:10.1038/nm1192 · Cited by 220
The RD114/simian type D retrovirus receptor is a neutral amino acid transporter
Rasko, J. E. J., Battini, J.-L., Gottschalk, R. J., Mazo, I., & Miller, A. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2129 · Cited by 220
A Stable System for the High-Titer Production of Multiply Attenuated Lentiviral Vectors
Klages, N., Zufferey, R., & Trono, D. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0103 · Cited by 219
Targeted Cell Entry of Lentiviral Vectors
Funke, S., Maisner, A., Mühlebach, M. D., Koehl, U., Grez, M., Cattaneo, R., Cichutek, K., & Buchholz, C. J. (2008) · Molecular Therapy · doi:10.1038/mt.2008.128 · Cited by 218
Lentiviral vectors for enhanced gene expression in human hematopoietic cells
Ramezani, A., Hawley, T. S., & Hawley, R. G. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0190 · Cited by 217
Setting the Boundaries of Chromatin Domains and Nuclear Organization
Labrador, M., & Corces, V. G. (2002) · Cell · doi:10.1016/s0092-8674(02)01004-8 · Cited by 217
The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain
Zennou, V., Serguera, C., Sarkis, C., Colin, P., Perret, E., Mallet, J., & Charneau, P. (2001) · Nature Biotechnology · doi:10.1038/88115 · Cited by 214
Gene transfer vectors derived from equine infectious anemia virus
Olsen, J. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300768 · Cited by 212
Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy
Azzouz, M., Le, T., Ralph, G. S., Walmsley, L., Monani, U. R., Lee, D. C. P., Wilkes, F., Mitrophanous, K. A., Kingsman, S. M., Burghes, A. H. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422922 · Cited by 209
Vandekerckhove, L., Christ, F., Van Maele, B., De Rijck, J., Gijsbers, R., Van den Haute, C., Witvrouw, M., & Debyser, Z. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1886-1896.2006 · Cited by 208
kvasir: Release for Publication
Kevin Bonham, P. D. (2016) · PubMed · doi:10.5281/zenodo.53206 · Cited by 206
Nègre, D., Mangeot, P.-E., Duisit, G., Blanchard, S., Vidalain, P.-O., Leissner, P., Winter, A.-J., Rabourdin-Combe, C., Mehtali, M., Moullier, P., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301292 · Cited by 206
Hanawa, H., Kelly, P. F., Nathwani, A. C., Persons, D. A., Vandergriff, J. A., Hargrove, P., Vanin, E. F., & Nienhuis, A. W. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0549 · Cited by 205
Schwarzwaelder, K., Howe, S. J., Schmidt, M., Brugman, M. H., Deichmann, A., Glimm, H., Schmidt, S., Prinz, C., Wissler, M., King, D. J. S., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31661 · Cited by 203
Continuous high-titer HIV-1 vector production
Ikeda, Y., Takeuchi, Y., Martin, F., Cosset, F.-L., Mitrophanous, K., & Collins, M. (2003) · Nature Biotechnology · doi:10.1038/nbt815 · Cited by 198
Self-citationWatson, D. J., Kobinger, G. P., Passini, M. A., Wilson, J. M., & Wolfe, J. H. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0584 · Cited by 198
Garvey, K. J., Oberste, M. S., Elser, J. E., Braun, M. J., & Gonda, M. A. (1990) · Virology · doi:10.1016/0042-6822(90)90424-p · Cited by 195
Use of CD134 As a Primary Receptor by the Feline Immunodeficiency Virus
Shimojima, M., Miyazawa, T., Ikeda, Y., McMonagle, E. L., Haining, H., Akashi, H., Takeuchi, Y., Hosie, M. J., & Willett, B. J. (2004) · Science · doi:10.1126/science.1092124 · Cited by 193
Self-citationTransient Gene Expression by Nonintegrating Lentiviral Vectors
Nightingale, S. J., Hollis, R. P., Pepper, K. A., Petersen, D., Yu, X.-J., Yang, C., Bahner, I., & Kohn, D. B. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.008 · Cited by 192
Self-Inactivating Lentiviral Vectors with U3 and U5 Modifications
Iwakuma, T., Cui, Y., & Chang, L.-J. (1999) · Virology · doi:10.1006/viro.1999.9850 · Cited by 187
HIV virology and pathogenetic mechanisms of infection: a brief overview
Fanales-Belasio, E., Raimondo, M., Suligoi, B., & Buttò, S. (2010) · Annali dellIstituto Superiore di Sanità · doi:10.1590/s0021-25712010000100002 · Cited by 183
Olmsted, R. A., Langley, R., Roelke, M. E., Goeken, R. M., Adger-Johnson, D., Goff, J. P., Albert, J. P., Packer, C., Laurenson, M. K., & Caro, T. M. (1992) · Journal of Virology · doi:10.1128/jvi.66.10.6008-6018.1992 · Cited by 179
Yang, S., Cohen, C. J., Peng, P. D., Zhao, Y., Cassard, L., Yu, Z., Zheng, Z., Jones, S., Restifo, N. P., Rosenberg, S. A., et al. (2008) · Gene Therapy · doi:10.1038/gt.2008.90 · Cited by 179
Zhang, F., Thornhill, S. I., Howe, S. J., Ulaganathan, M., Schambach, A., Sinclair, J., Kinnon, C., Gaspar, H. B., Antoniou, M., & Thrasher, A. J. (2007) · Blood · doi:10.1182/blood-2006-12-060814 · Cited by 176
Production and concentration of pseudotyped HIV-1-based gene transfer vectors
Reiser, J. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301188 · Cited by 175
Stable Gene Transfer to Muscle Using Non-integrating Lentiviral Vectors
Apolonia, L., Waddington, S. N., Fernandes, C., Ward, N. J., Bouma, G., Blundell, M. P., Thrasher, A. J., Collins, M. K., & Philpott, N. J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300281 · Cited by 174
Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells
Kootstra, N. A., Münk, C., Tonnu, N., Landau, N. R., & Verma, I. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337541100 · Cited by 174
Phosphatidylserine Is Not the Cell Surface Receptor for Vesicular Stomatitis Virus
Coil, D. A., & Miller, A. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.10920-10926.2004 · Cited by 174
Beyer, W. R., Westphal, M., Ostertag, W., & von Laer, D. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1488-1495.2002 · Cited by 174
Herold, M. J., van den Brandt, J., Seibler, J., & Reichardt, H. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806213105 · Cited by 169
A Phase I/II Clinical Trial of β‐Globin Gene Therapy for β‐Thalassemia
BANK, A., DORAZIO, R., & LEBOULCH, P. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.007 · Cited by 169
Generation of a Stable Cell Line Producing High-Titer Self-Inactivating Lentiviral Vectors
Xu, K., Ma, H., McCown, T. J., Verma, I. M., & Kafri, T. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0238 · Cited by 168
Comparison of lentiviral vector titration methods
Geraerts, M., Willems, S., Baekelandt, V., Debyser, Z., & Gijsbers, R. (2006) · BMC Biotechnology · doi:10.1186/1472-6750-6-34 · Cited by 167
Yu, X., Zhan, X., D'Costa, J., Tanavde, V. M., Ye, Z., Peng, T., Malehorn, M. T., Yang, X., Civin, C. I., & Cheng, L. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00104-7 · Cited by 165
Frecha, C., Costa, C., Nègre, D., Gauthier, E., Russell, S. J., Cosset, F.-L., & Verhoeyen, E. (2008) · Blood · doi:10.1182/blood-2008-05-155945 · Cited by 164
Targeting lentiviral vectors to specific cell types in vivo
Yang, L., Bailey, L., Baltimore, D., & Wang, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604993103 · Cited by 161
Hanawa, H., Hematti, P., Keyvanfar, K., Metzger, M. E., Krouse, A., Donahue, R. E., Kepes, S., Gray, J., Dunbar, C. E., Persons, D. A., et al. (2004) · Blood · doi:10.1182/blood-2004-01-0045 · Cited by 159
Wang, G., Slepushkin, V., Zabner, J., Keshavjee, S. H., Johnston, J., Sauter, S. L., Jolly, D. J., Dubensky, T. W., Davidson, B. L., & McCray, P. B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8390 · Cited by 157
Throm, R. E., Ouma, A. A., Zhou, S., Chandrasekaran, A., Lockey, T. D., Greene, M. R., Ravin, S. S. D., Moayeri, M., Malech, H. L., Sorrentino, B. P., et al. (2009) · Blood · doi:10.1182/blood-2008-11-191049 · Cited by 154
A New-Generation Stable Inducible Packaging Cell Line for Lentiviral Vectors
Farson, D. A., Witt, R. M., MCGUINNESS, R. P., Dull, T., Kelly, M., Song, J., Radeke, R., Bukovsky, A., Consiglio, A., & Naldini, L. (2001) · Human Gene Therapy · doi:10.1089/104303401750195935 · Cited by 153
Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters
Hioki, H., Kameda, H., Nakamura, H., Okunomiya, T., Ohira, K., Nakamura, K., Kuroda, M., Furuta, T., & Kaneko, T. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302924 · Cited by 153
Esslinger, C., Chapatte, L., Finke, D., Miconnet, I., Guillaume, P., Lévy, F., & MacDonald, H. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17098 · Cited by 150
Manilla, P., Rebello, T., Afable, C., Lü, X., Slepushkin, V., Humeau, L. M. P. F., Schonely, K., Ni, Y., Binder, G. K., Levine, B. L., et al. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.17 · Cited by 149
Pfeifer, A., Eigenbrod, S., Al-Khadra, S., Hofmann, A., Mitteregger, G., Moser, M., Bertsch, U., & Kretzschmar, H. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29236 · Cited by 149
Dvorin, J. D., Bell, P., Maul, G. G., Yamashita, M., Emerman, M., & Malim, M. H. (2002) · Journal of Virology · doi:10.1128/jvi.76.23.12087-12096.2002 · Cited by 149
Vigna, E., Cavalieri, S., Ailles, L., Geuna, M., Loew, R., Bujard, H., & Naldini, L. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0542 · Cited by 147
Highly Efficient Multicistronic Lentiviral Vectors with Peptide 2A Sequences
Ibrahimi, A., Velde, G. V., Reumers, V., Toelen, J., Thiry, I., Vandeputte, C., Vets, S., Deroose, C. M., Bormans, G. M., Baekelandt, V., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2008.188 · Cited by 145
Wagner, R., Graf, M., Bieler, K., Wolf, H. J., Grunwald, T., Foley, P., & Überla, K. (2000) · Human Gene Therapy · doi:10.1089/104303400750038507 · Cited by 141
Zhang, F., Frost, A. R., Blundell, M. P., Bales, O., Antoniou, M. N., & Thrasher, A. J. (2010) · Molecular Therapy · doi:10.1038/mt.2010.132 · Cited by 139
Development of a Novel Trans-Lentiviral Vector That Affords Predictable Safety
Wu, X., Wakefield, J. K., Liu, H., Xiao, H., Kralovics, R., Prchal, J. T., & Kappes, J. C. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0095 · Cited by 137
The phylogenetic history of immunodeficiency viruses
Smith, T. F., Srinivasan, A., Schochetman, G., et al. (1988) · Nature · doi:10.1038/333573a0 · Cited by 137
Stitz, J., Buchholz, C. J., Engelstädter, M., Uckert, W., Bloemer, U., Schmitt, I., & Cichutek, K. (2000) · Virology · doi:10.1006/viro.2000.0394 · Cited by 135
Maele, B. V., Rijck, J. D., Clercq, E. D., & Debyser, Z. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4685-4694.2003 · Cited by 134
Arumugam, P. I., Scholes, J., Perelman, N., Xia, P., Yee, J., & Malik, P. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300259 · Cited by 130
Gasmi, M., Glynn, J. M., Jin, M., Jolly, D. J., Yee, J., & Chen, S. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1828-1834.1999 · Cited by 129
Postentry Restriction to Human Immunodeficiency Virus-Based Vector Transduction in Human Monocytes
Neil, S. J. D., Martín, F., Ikeda, Y., & Collins, M. K. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5448-5456.2001 · Cited by 125
Self-citationSaenz, D. T., Loewen, N. A., Peretz, M., Whitwam, T., Barraza, R., Howell, K. G., Holmes, J. M., Good, M. S., & Poeschla, E. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2906-2920.2004 · Cited by 122
High Levels of Transduction of Human Dendritic Cells with Optimized SIV Vectors
Mangeot, P.-E., Duperrier, K., Négre, D., Boson, B., Rigal, D., Cosset, F., & Darlix, J. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0541 · Cited by 121
Otto, E., Jones-Trower, A., Vanin, E. F., Stambaugh, K., Mueller, S. N., Anderson, W. F., & McGarrity, G. J. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.5-567 · Cited by 120
Sinn, P. L., Hickey, M. A., Staber, P. D., Dylla, D. E., Jeffers, S. A., Davidson, B. L., Sanders, D. A., & McCray, P. B. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.5902-5910.2003 · Cited by 118
Lentivirus Vectors Using Human and Simian Immunodeficiency Virus Elements
White, S. M., Renda, M. J., Nam, N.-Y., Klimatcheva, E., Zhu, Y., Fisk, J., Halterman, M., Rimel, B. J., Federoff, H. J., Pandya, S., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2832-2840.1999 · Cited by 116
Pfeifer, A., Keßler, T., Yang, M., Baranov, E., Kootstra, N. A., Cheresh, D. A., Hoffman, R. M., & Verma, I. M. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0276 · Cited by 116
Richardson, J. H., Child, L. A., & Lever, A. M. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3997-4005.1993 · Cited by 114
Pichlmair, A., Diebold, S. S., Gschmeissner, S., Takeuchi, Y., Ikeda, Y., Collins, M. K., & Sousa, C. R. E. (2006) · Journal of Virology · doi:10.1128/jvi.01818-06 · Cited by 114
Self-citationEfficient Transduction of Nondividing Cells by Optimized Feline Immunodeficiency Virus Vectors
Curran, M. A., Kaiser, S. M., Achacoso, P. L., & Nolan, G. P. (2000) · Molecular Therapy · doi:10.1006/mthe.1999.0007 · Cited by 112
Rowe, H. M., Lopes, L. M., Ikeda, Y., Bailey, R., Barde, I., Zenke, M., Chain, B., & Collins, M. K. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.025 · Cited by 111
Self-citationIntravenous Injection of a Lentiviral Vector Encoding NY-ESO-1 Induces an Effective CTL Response
Palmowski, M. J., Lopes, L. M., Ikeda, Y., Salio, M., Cerundolo, V., & Collins, M. K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1582 · Cited by 109
Self-citationRestriction of Feline Immunodeficiency Virus by Ref1, Lv1, and Primate TRIM5α Proteins
Saenz, D. T., Teo, W., Olsen, J. C., & Poeschla, E. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15175-15188.2005 · Cited by 109
Maurice, M., Verhoeyen, E., Salmon, P., Trono, D., Russell, S. J., & Cosset, F. (2002) · Blood · doi:10.1182/blood.v99.7.2342 · Cited by 107
Wilber, A. C., Hargrove, P. W., Kim, Y., Riberdy, J. M., Sankaran, V. G., Papanikolaou, E., Georgomanoli, M., Anagnou, N. P., Orkin, S. H., Nienhuis, A. W., et al. (2010) · Blood · doi:10.1182/blood-2010-08-300723 · Cited by 107
Park, F., & Kay, M. A. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0450 · Cited by 106
Poeschla, E. M., Gilbert, J., Li, X., Huang, S., Ho, A. D., & Wong‐Staal, F. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6527-6536.1998 · Cited by 106
Berger, G., Durand, S., Goujon, C., Nguyen, X.-N., Cordeil, S., Darlix, J., & Cimarelli, A. (2011) · Nature Protocols · doi:10.1038/nprot.2011.327 · Cited by 105
The art gene product of human immunodeficiency virus is required for replication
Terwilliger, E., Burghoff, R. L., Sia, R. A. L., Sodroski, J., Haseltine, W. A., & Rosen, C. A. (1988) · Journal of Virology · doi:10.1128/jvi.62.2.655-658.1988 · Cited by 103
Chinen, J., Davis, J., Ravin, S. S. D., Hay, B. N., Hsu, A. P., Linton, G. F., Naumann, N., Nomicos, E. Y. H., Silvin, C. J., Ulrick, J., et al. (2007) · Blood · doi:10.1182/blood-2006-11-058933 · Cited by 102
Applications of Lentiviral Vectors for shRNA Delivery and Transgenesis
Singer, O., & Verma, I. M. (2008) · Current Gene Therapy · doi:10.2174/156652308786848067 · Cited by 99
Replication and pathogenesis of the AIDS virus.
Haseltine, W. A. (1988) · PubMed · Cited by 98
Biomedicine and Diseases: Review¶Assembling the human immunodeficiency virus type 1
Cimarelli, A., & Darlix, J. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8495-6 · Cited by 93
Aker, M., Tubb, J., Groth, A. C., Bukovsky, A. A., Bell, A. C., Felsenfeld, G., Kiem, H., Stamatoyannopoulos, G., & Emery, D. W. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.021 · Cited by 92
Escarpe, P. A., Zayek, N., Chin, P. S., Borellini, F., Zufferey, R., Veres, G., & Kiermer, V. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00167-9 · Cited by 90
Zanta, M.-A., Charrier, S., Brice-Ouzet, A., Martin, S., Opolon, P., Thrasher, A. J., Hope, T. J., & Galy, A. H. M. (2009) · Gene Therapy · doi:10.1038/gt.2009.3 · Cited by 89
Ni, Y., Sun, S. Y., Oparaocha, I., Humeau, L. M. P. F., Davis, B., Cohen, R., Binder, G. K., Chang, Y., Slepushkin, V., & Dropulić, B. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.726 · Cited by 88
Influence of gag on Human Immunodeficiency Virus Type 1 Species-Specific Tropism
Ikeda, Y., Ylinen, L. M. J., Bador, M. K., & Towers, G. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11816-11822.2004 · Cited by 87
Self-citationHIV-1 infection of non-dividing cells
Freed, E. O., & Martin, M. A. (1994) · Nature · doi:10.1038/369107b0 · Cited by 85
Kingsman, S. M., Mitrophanous, K., & Olsen, J. C. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302417 · Cited by 84
Jones, S., Peng, P. D., Yang, S., Hsu, C., Cohen, C. J., Zhao, Y., Abad, J., Zheng, Z., Rosenberg, S. A., & Morgan, R. A. (2009) · Human Gene Therapy · doi:10.1089/hum.2008.048 · Cited by 84
Gene transduction efficiency in cells of different species by HIV and EIAV vectors
Ikeda, Y., Collins, M. K., Radcliffe, P. A., Mitrophanous, K., & Takeuchi, Y. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301708 · Cited by 84
Self-citationConditional Expression of Genes in the Respiratory Epithelium in Transgenic Mice
Perl, A. T., Zhang, L., & Whitsett, J. A. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0011ed · Cited by 81
Pacchia, A. L., Adelson, M. E., Kaul, M., Ron, Y., & Dougherty, J. P. (2001) · Virology · doi:10.1006/viro.2000.0787 · Cited by 76
Papapetrou, E., & Sadelain, M. (2011) · Nature Protocols · doi:10.1038/nprot.2011.374 · Cited by 75
Lentivirally generated eGFP‐transgenic rats allow efficient cell tracking in vivo
van den Brandt, J., Wang, D., Kwon, S., Heinkelein, M., & Reichardt, H. M. (2004) · genesis · doi:10.1002/gene.20037 · Cited by 75
Lopes, L. M., Dewannieux, M., Gileadi, U., Bailey, R., Ikeda, Y., Whittaker, C., Collin, M. P., Cerundolo, V., Tomihari, M., Ariizumi, K., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01289-07 · Cited by 75
Self-citationMaturation of the HIV reverse transcription complex: putting the jigsaw together
Warrilow, D., Tachedjian, G., & Harrich, D. (2009) · Reviews in Medical Virology · doi:10.1002/rmv.627 · Cited by 74
Strang, B. L., Ikeda, Y., Cosset, F., Collins, M. K., & Takeuchi, Y. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302189 · Cited by 73
Self-citationLü, X., Humeau, L. M. P. F., Slepushkin, V., Binder, G. K., Yu, Q., Slepushkina, T., Chen, Z., Merling, R. K., Davis, B., Chang, Y., et al. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.593 · Cited by 68
In vivo imaging of ligand receptor binding with Gaussia luciferase complementation
Luker, K. E., Mihalko, L. A., Schmidt, B. T., Lewin, S. A., Ray, P., Shcherbo, D. S., Chudakov, D. M., & Luker, G. D. (2011) · Nature Medicine · doi:10.1038/nm.2590 · Cited by 68
Lentiviral Vectors Encoding HIV-1 Polyepitopes Induce Broad CTL Responses In Vivo
Iglesias, M. C., Mollier, K., Beignon, A., Souque, P., Adotévi, O., Lemonnier, F. A., & Charneau, P. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300135 · Cited by 64
Sastry, L., Xu, Y., Johnson, T., Desai, K., Rissing, D., Marsh, J. A., & Cornetta, K. G. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.08.003 · Cited by 63
rtTA toxicity limits the usefulness of the SP-C-rtTA transgenic mouse
Morimoto, M., & Kopan, R. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2008.10.013 · Cited by 62
Bobisse, S., Rondina, M., Merlo, A., Tisato, V., Mandruzzato, S., Amendola, M., Naldini, L., Willemsen, R. A., Debets, R., Zanovello, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0494 · Cited by 62
Antiviral restriction factor transgenesis in the domestic cat
Wongsrikeao, P., Saenz, D. T., Rinkoski, T. A., Otoi, T., & Poeschla, E. M. (2011) · Nature Methods · doi:10.1038/nmeth.1703 · Cited by 62
A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors
Cockrell, A. S., Ma, H., Fu, K., McCown, T. J., & Kafri, T. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.12.015 · Cited by 62
Thatava, T., Armstrong, A. S., Lamo, J. G. D., Edukulla, R., Khan, Y. K., Sakuma, T., Ohmine, S., Sundsbak, J. L., Harris, P. C., Kudva, Y. C., et al. (2011) · Stem Cell Research & Therapy · doi:10.1186/scrt89 · Cited by 62
Self-citationBrun, S., Biguet, N. F., & Mallet, J. J. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00097-2 · Cited by 61
Deroose, C. M., Reumers, V., Gijsbers, R., Bormans, G. M., Debyser, Z., Mortelmans, L. A., & Baekelandt, V. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.007 · Cited by 61
Terwilliger, E., Godin, B., Sodroski, J., & Haseltine, W. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3857 · Cited by 60
Cited by
Lee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zeng, Z., Shu, Y., Wu, X., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.04.001 · Cited by 691
Gene therapy: Comprehensive overview and therapeutic applications
Sayed, N., Allawadhi, P., Khurana, A., Singh, V., Navik, U., Pasumarthi, S. K., Khurana, I., Banothu, A. K., Weiskirchen, R., & Bharani, K. K. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120375 · Cited by 337
(2013) · PubMed · Cited by 308
Betibeglogene Autotemcel Gene Therapy for Non–β 0 /β 0 Genotype β-Thalassemia
Locatelli, F., Thompson, A. A., Kwiatkowski, J. L., Porter, J. B., Thrasher, A. J., Hongeng, S., Sauer, M. G., Thuret, I., Lal, A., Algeri, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2113206 · Cited by 283
Challenges and new technologies in adoptive cell therapy
Zhang, P., Zhang, G., & Wan, X. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01492-8 · Cited by 259
Metadata
- Authors
- Sakuma, T., Barry, M. A., & Ikeda, Y.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2012-04-16
- Volume
- 443
- Issue
- 3
- Pages
- 603-618
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2140344320
- Cited by
- 336
- References
- 228
- FWCI
- 17.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.